The global $silver market is projected to record its sixth consecutive annual supply deficit in 2026.
I’m still holding 40% of my $SLV position that I bought in 2022. From a technical perspective, the chart is forming what…
Read post
$MU, three good questions to ask yourself:
My conclusion? Getting long here doesn’t make much sense to me. For now, it’s either short or nothing. That said, the bullish…
Read post
$PLTR remains in free fall and is now in no man’s land.
I’m still fully short, including the day-trade position that I decided to hold overnight last week. The $100 zone remains my first…
Read post
$SNDK down 5% at the moment, but don’t worry… the worst is yet to come.
Why am I bearish?👇 Study historical extreme buy climaxes and what usually happens next. Don’t take my word for it, study the…
Read post
$MU / $SNDK
A low PE ratio doesn’t stop a stock from falling, just like a high PE ratio doesn’t stop it from rising. Price…
Read post
$SNDK is likely to correct at least 30% and possibly even 60%
Shorted this in the pre market and will hold through$MU earnings I am still on a large open profit.
Read post
$PLTR
The $100 magnet is pulling hard. I think the odds are increasing that bulls give up defending soon. I don’t believe $100…
Read post
Palantir Stock Analysis: Why I Remain Short $PLTR
Palantir ($PLTR) has been one of the market’s biggest winners over the past few years. Strong enthusiasm around artificial intelligence, government contracts,…
Read post
$PLTR
The bear party has started. I remain fully short. My advice? FASTEN YOUR SEATBELTS. 🎢🐻
Read post
$NVO, CVS is making GLP-1 drugs easier to access with $49 virtual visits and prescription support.
More access = more potential patients. The obesity drug market is still in its early innings. Not holding many longs right now,…
Read post